Joel Morganroth
Director/Board Member at ACR Image Metrix
Profile
Joel Morganroth is currently a Director at ACR Image Metrix and Eleison Pharmaceuticals, Inc. He was previously the President, Chief Executive Officer & Director at ERT Operating Co. from 1997 to 1999.
He also worked as a Clinical Professor-Medicine at Perelman School of Medicine.
Dr. Morganroth received his undergraduate and doctorate degrees from the University of Michigan in 1966 and 1970, respectively.
Joel Morganroth active positions
| Companies | Position | Start |
|---|---|---|
| ACR Image Metrix | Director/Board Member | 2011-10-26 |
Eleison Pharmaceuticals, Inc.
 Eleison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Eleison Pharmaceuticals, Inc. engages in the acquisition, development and commercialization of clinical stage drug candidates for orphan oncology indications. Its portfolio of drug candidates consists of glufosfamide, inhaled lipid-complexed cisplatin (ILC) and dibromodulcitol (DBD). The company was founded by Edwin J. Thomas on October 14, 2009 and is headquartered in Princeton, NJ. | Director/Board Member | 2017-12-31 |
Former positions of Joel Morganroth
| Companies | Position | End |
|---|---|---|
| Perelman School of Medicine | Corporate Officer/Principal | - |
ERT Operating Co.
 ERT Operating Co. Miscellaneous Commercial ServicesCommercial Services ERT Operating Co. engages in the provision of centralized electrocardiographic services. It offers safety and efficacy endpoint collection, data integration and analytics, and real-world evidence. The company was founded in 1977 and is headquartered in Philadelphia, PA. | Chief Executive Officer | 2011-04-29 |
Training of Joel Morganroth
| University of Michigan | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
ERT Operating Co.
ERT Operating Co. Miscellaneous Commercial ServicesCommercial Services ERT Operating Co. engages in the provision of centralized electrocardiographic services. It offers safety and efficacy endpoint collection, data integration and analytics, and real-world evidence. The company was founded in 1977 and is headquartered in Philadelphia, PA. | Commercial Services |
| ACR Image Metrix | |
Eleison Pharmaceuticals, Inc.
Eleison Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Eleison Pharmaceuticals, Inc. engages in the acquisition, development and commercialization of clinical stage drug candidates for orphan oncology indications. Its portfolio of drug candidates consists of glufosfamide, inhaled lipid-complexed cisplatin (ILC) and dibromodulcitol (DBD). The company was founded by Edwin J. Thomas on October 14, 2009 and is headquartered in Princeton, NJ. | Health Technology |
- Stock Market
- Insiders
- Joel Morganroth
